Literature DB >> 17433451

Myelin staining of deep white matter in the dorsolateral prefrontal cortex in schizophrenia, bipolar disorder, and unipolar major depression.

William T Regenold1, Pornima Phatak, Christopher M Marano, Lorie Gearhart, Claudia H Viens, K Calvin Hisley.   

Abstract

Neuroimaging and postmortem studies suggest the involvement of white matter disease in schizophrenia, bipolar disorder, and unipolar major depression. To date there is no published, collective study of myelin staining in these three psychiatric disorders. Deep white matter lesions, potentially affecting corticolimbic circuits, have been particularly implicated in late life depression and poor outcome bipolar disorder. We hypothesized that individuals with these disorders would manifest reduced deep white matter myelin staining compared to normal controls. Sixty transverse sections of fixed dorsolateral prefrontal cortex - 15 from individuals with each psychiatric disorder and 15 from normal controls - were stained according to the method of Kluver and Barrera. Myelin staining intensity was quantified by digital image analysis and expressed as a percent of grey matter staining for a given section. Mean deep (but not gyral) white matter myelin staining was less intense in all three psychiatric groups compared to control. This difference was statistically significant for the bipolar and unipolar groups, with a strong trend toward attenuated staining in the schizophrenic group. Our findings are consistent with postmortem and neuroimaging studies of affective disorders that indicate an increased prevalence of deep white matter lesions in unipolar and bipolar affective disorders.

Entities:  

Mesh:

Year:  2007        PMID: 17433451     DOI: 10.1016/j.psychres.2006.12.019

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  58 in total

Review 1.  Neuroglialpharmacology: myelination as a shared mechanism of action of psychotropic treatments.

Authors:  George Bartzokis
Journal:  Neuropharmacology       Date:  2012-01-28       Impact factor: 5.250

Review 2.  Glial abnormalities in substance use disorders and depression: does shared glutamatergic dysfunction contribute to comorbidity?

Authors:  Mark J Niciu; Ioline D Henter; Gerard Sanacora; Carlos A Zarate
Journal:  World J Biol Psychiatry       Date:  2013-09-12       Impact factor: 4.132

Review 3.  Better understanding of mechanisms of schizophrenia and bipolar disorder: from human gene expression profiles to mouse models.

Authors:  Chi-Ying Lin; Akira Sawa; Hanna Jaaro-Peled
Journal:  Neurobiol Dis       Date:  2011-09-03       Impact factor: 5.996

Review 4.  Elevated immune-inflammatory signaling in mood disorders: a new therapeutic target?

Authors:  Robert K McNamara; Francis E Lotrich
Journal:  Expert Rev Neurother       Date:  2012-09       Impact factor: 4.618

Review 5.  Epigenetic dysregulation in schizophrenia: molecular and clinical aspects of histone deacetylase inhibitors.

Authors:  Alkomiet Hasan; Amanda Mitchell; Anja Schneider; Tobias Halene; Schahram Akbarian
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2013-02-05       Impact factor: 5.270

6.  Myt1L Promotes Differentiation of Oligodendrocyte Precursor Cells and is Necessary for Remyelination After Lysolecithin-Induced Demyelination.

Authors:  Yanqing Shi; Qi Shao; Zhenghao Li; Ginez A Gonzalez; Fengfeng Lu; Dan Wang; Yingyan Pu; Aijun Huang; Chao Zhao; Cheng He; Li Cao
Journal:  Neurosci Bull       Date:  2018-02-03       Impact factor: 5.203

7.  A comprehensive tractography study of patients with bipolar disorder and their unaffected siblings.

Authors:  Emma Sprooten; Jennifer Barrett; D Reese McKay; Emma E Knowles; Samuel R Mathias; Anderson M Winkler; Margaret S Brumbaugh; Stefanie Landau; Lindsay Cyr; Peter Kochunov; David C Glahn
Journal:  Hum Brain Mapp       Date:  2016-05-16       Impact factor: 5.038

8.  Altered intracortical myelin staining in the dorsolateral prefrontal cortex in severe mental illness.

Authors:  Evelyn M R Lake; Eric A Steffler; Christopher D Rowley; Manpreet Sehmbi; Luciano Minuzzi; Benicio N Frey; Nicholas A Bock
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2016-09-14       Impact factor: 5.270

9.  DTI tractography and white matter fiber tract characteristics in euthymic bipolar I patients and healthy control subjects.

Authors:  Carinna M Torgerson; Andrei Irimia; Alex D Leow; George Bartzokis; Teena D Moody; Robin G Jennings; Jeffry R Alger; John Darrell Van Horn; Lori L Altshuler
Journal:  Brain Imaging Behav       Date:  2013-06       Impact factor: 3.978

Review 10.  Neurocircuitry of mood disorders.

Authors:  Joseph L Price; Wayne C Drevets
Journal:  Neuropsychopharmacology       Date:  2010-01       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.